Ablation of Neuroaxial in Patients with Ventricular Tachycardia
Copyright © 2019 Elsevier Inc. All rights reserved..
Ventricular tachycardia (VT) remains a common cause of sudden cardiac death. It is widely accepted that VTs are strongly associated with autonomic imbalance with reduced vagal and increased sympathetic activities. Pharmacologic therapy remains the first-line therapy, but antiarrhythmic agents may not be effective or carry significant side effects. Sympathetic denervation is an emerging therapy to prevent or treat VTs by rebalancing the sympathetic and parasympathetic activity. This article focuses on the role of sympathetic activation in VT, and the mapping and ablation of sympathetic nervous system in patients with VT.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Cardiac electrophysiology clinics - 11(2019), 4 vom: 15. Dez., Seite 625-634 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Yuhong [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Autonomic nervous system |
|---|
| Anmerkungen: |
Date Completed 09.03.2020 Date Revised 09.03.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ccep.2019.08.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM303102519 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM303102519 | ||
| 003 | DE-627 | ||
| 005 | 20231225112125.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ccep.2019.08.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1010.xml |
| 035 | |a (DE-627)NLM303102519 | ||
| 035 | |a (NLM)31706470 | ||
| 035 | |a (PII)S1877-9182(19)30102-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Yuhong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ablation of Neuroaxial in Patients with Ventricular Tachycardia |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.03.2020 | ||
| 500 | |a Date Revised 09.03.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier Inc. All rights reserved. | ||
| 520 | |a Ventricular tachycardia (VT) remains a common cause of sudden cardiac death. It is widely accepted that VTs are strongly associated with autonomic imbalance with reduced vagal and increased sympathetic activities. Pharmacologic therapy remains the first-line therapy, but antiarrhythmic agents may not be effective or carry significant side effects. Sympathetic denervation is an emerging therapy to prevent or treat VTs by rebalancing the sympathetic and parasympathetic activity. This article focuses on the role of sympathetic activation in VT, and the mapping and ablation of sympathetic nervous system in patients with VT | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Autonomic nervous system | |
| 650 | 4 | |a Left cardiac sympathetic denervation | |
| 650 | 4 | |a Renal sympathetic denervation | |
| 650 | 4 | |a Sympathetic activation | |
| 650 | 4 | |a Ventricular tachycardia | |
| 700 | 1 | |a Yu, Lilei |e verfasserin |4 aut | |
| 700 | 1 | |a Po, Sunny S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiac electrophysiology clinics |d 2009 |g 11(2019), 4 vom: 15. Dez., Seite 625-634 |w (DE-627)NLM20753540X |x 1877-9190 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2019 |g number:4 |g day:15 |g month:12 |g pages:625-634 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ccep.2019.08.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2019 |e 4 |b 15 |c 12 |h 625-634 | ||